Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies

Wexler, T. L., & Page‐Wilson, G. (2023). Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies. British Journal of Clinical Pharmacology, 89(4), 1304–1317. Portico. https://doi.org/10.1111/bcp.15660
Authors:
Tamara L Wexler
Gabrielle Page-Wilson
Affiliated Authors:
Gabrielle Page-Wilson
Columbia Affiliation:
Subjects:
Dopamine Agonists (MeSH)
Pituitary Neoplasms (MeSH)
Prolactinoma (MeSH)
Author Keywords:
dopamine agonists
drug information
neuroendocrinology
pharmacotherapy
pituitary adenomas
pituitary tumours
prescribing
elink
Publication Type:
Article
Unique ID:
10.1111/bcp.15660
PMID:
36630197
DOI:
10.1111/bcp.15660
Journal:
British Journal of Clinical Pharmacology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: